Health Care Select Sector SPDR Fund (XLV)
| Assets | $40.39B |
| Expense Ratio | 0.08% |
| PE Ratio | 22.53 |
| Shares Out | 261.77M |
| Dividend (ttm) | $2.44 |
| Dividend Yield | 1.59% |
| Ex-Dividend Date | Sep 22, 2025 |
| Payout Ratio | 35.85% |
| 1-Year Return | +4.44% |
| Volume | 8,850,025 |
| Open | 154.45 |
| Previous Close | 153.90 |
| Day's Range | 152.96 - 154.63 |
| 52-Week Low | 127.35 |
| 52-Week High | 158.95 |
| Beta | 0.62 |
| Holdings | 63 |
| Inception Date | Dec 16, 1998 |
About XLV
Fund Home PageThe Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that is based on the S&P Health Care Select Sector index. The fund tracks health care stocks from within the S&P 500 Index, weighted by market cap. XLV was launched on Dec 16, 1998 and is issued by State Street.
Top 10 Holdings
57.76% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 14.44% |
| Johnson & Johnson | JNJ | 8.73% |
| AbbVie Inc. | ABBV | 7.23% |
| UnitedHealth Group Incorporated | UNH | 5.41% |
| Merck & Co., Inc. | MRK | 4.51% |
| Abbott Laboratories | ABT | 3.91% |
| Thermo Fisher Scientific Inc. | TMO | 3.89% |
| Intuitive Surgical, Inc. | ISRG | 3.65% |
| Amgen Inc. | AMGN | 3.28% |
| Gilead Sciences, Inc. | GILD | 2.72% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2025 | $0.62487 | Sep 24, 2025 |
| Jun 23, 2025 | $0.63038 | Jun 25, 2025 |
| Mar 24, 2025 | $0.56454 | Mar 26, 2025 |
| Dec 23, 2024 | $0.62166 | Dec 26, 2024 |
| Sep 23, 2024 | $0.57723 | Sep 25, 2024 |
| Jun 24, 2024 | $0.57253 | Jun 26, 2024 |
News
Historic Health Care Relative Strength
While stocks are getting off to a quiet start to December, the S&P 500 staged a solid recovery in the final week of November to manage a modest 13 bps gain on the month. A majority of sectors actually...
XLV: The Simple Case For Overweighting U.S. Health Care
The H ealth Care Select Sector SPDR is comprised of all the Health Care stocks inside the S&P 500 Index. Its expense ratio is only 0.08% and XLV has $41.2B in AUM. The simple case for overweighting U....
State Street Now Distributor for Select Sector SPDR ETFs
State Street Investment Management (SSIM) has been the investment advisor for the Select Sector SPDR ETFs since 1998. It will now take over the distribution and marketing for these funds.
Healthcare ETFs: I Prefer VHT's Growth To XLV's Stability
Vanguard Health Care ETF and Health Care Select Sector SPDR Fund both benefit from healthcare innovation tailwinds, earning a buy rating. VHT offers broader diversification and greater exposure to sma...
Josh Brown's ‘best stocks in the market': Health Care
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's spotlighting Health Care in his "best stocks in the market." The Committee debates their health care s...
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in...
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
Several large-cap drugmakers have been climbing and are bringing the sector higher. There's also a flight to safety, as investors reallocate funds from high-flying tech stocks.
If M&A continues at this pace you want to be long Biotech into next year, says Mizuho's Jared Holz
Jared Holz, Mizuho, joins 'Fast Money' to talk the uptick in biotech and pharma M&A, what it is signaling, and how to play it.
Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman
Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.
'Fast Money' traders talk how to play biopharma space
The 'Fast Money' traders talk how to play biopharma space.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discoun...
Momentum and private assets: The trends driving ETFs to record inflows
ETF inflows are already at record annual flows. Todd Rosenbluth, VettaFi head of research, on what's driving the momentum and the trends that are standing out.
Schwab IMPACT 2025: Record $13T in ETFs & What's Next for ETF Assets
Matt Camuso, Head of ETF Solutions at BNY Investments, says there are $13 trillion of assets in ETFs. That's compared to $5 trillion a year prior.
State Street's Anna Paglia on why the firm is shifting from ETFs to mutual funds
Anna Paglia, State Street Investment Research CBO and chief business officer, joins CNBC's Dom Chu on the type of assets and ETFs State Street is seeing the flows into. She also shares why the firm is...
2 Classic ETFs Were Back in Favor in October
State Street Investment Management (SSIM) is home to the lowest-cost S&P 500 ETF — the SPDR Portfolio S&P 500 ETF (SPYM) — and the largest gold ETF, SPDR Gold Shares (GLD). Though these two ETFs have ...
Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin
Right now ahead of Halloween, the real suspense might be in ETF investing strategies. With markets seesawing between hopes for rate cuts and the resilience of earnings, investors are dusting off one o...
The Utterly Tranquil Feeling Of Watching Your Passive Income Grow
Dividend growth investing offers reliable, passive income and personal tranquility, more so than non-dividend strategies and rental property investing. Current market valuations, especially in Big Tec...
October's 5 Dividend Growth Stocks With Yields Up To 8.33%
Every month, we screen for high-yield dividend yields, but those that also deliver relatively consistent growth with regular dividend increases. The parameters of the screening also include dividend s...
XLV: Lower Interest Rates And A Positive Growth Outlook Will Pave The Way
The Fed has begun to reduce interest rates in the U.S. This decision will incentivize the deployment of funding in the healthcare industry. The top holdings of XLV are profitable firms, with a median ...
AI train is moving to non-tech sectors like financials and health care: BofA's Savita Subramanian
Savita Subramanian, Bank of America Securities head of equity and quantitative strategy, joins 'The Exchange' to discuss the current market catalysts and concerns.
New Prescription for Gains: Behind Q4 Healthcare Lead
It's early days, but the fourth quarter has brought a change in market leadership at the sector level. Healthcare, one of the year's big laggards, is now the best performing S&P 500 sector so far in O...
What AMD's OpenAI deal means for Nvidia, healthcare stocks see major gains in 2025
Morning Brief: Market Sunrise anchor Ramzan Karmali examines the biggest market news and stories for October 7, 2025. CFRA research analyst Angelo Zino comes on the program to talk more about AMD's AI...
Confluence of factors are bringing investment into biotech sector, says StemPoint's Michelle Ross
Michelle Ross, StemPoint Capital CIO, joins 'Closing Bell' to discuss Ross' thoughts on the recent news in the biotech space, what the CIO expects to continue and much more.